MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3

Oncology Letters

Volumn 10, Issue 3, 2015, Pages 1447-1452

  Yu, Zhanjiang ^a   Zhang, Wei ^a   Deng, Fengchun ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Cell growth; E2F transcription factor 3; Gastric cancer; MicroRNA 577

Indexed keywords

MICRORNA; MICRORNA 577; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL LINE; CELL CYCLE ASSAY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84937442267     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3390     Document Type: Article

References (33)

1. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed March 31, 2014.
2. FockKM: Review article: The epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther40: 250-260, 2014.
3. FerlayJ, SoerjomataramI, ErvikM, etal; International Agency for Research on Cancer: GLOBOCAN 2012: Cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr. Accessed November 20, 2014.
4. HowladerN, NooneAM, KrapchoM, etal; National Cancer Institute: SEER Cancer statistics review, 1975-2011. http://seer.cancer.gov/csr/1975_2011/. Accessed June 21, 2014.
5. MakeyevEV and ManiatisT: Multilevel regulation of gene expression by microRNAs. Science319: 1789-1790, 2008.
6. BushatiN and CohenSM: microRNA functions. Annu Rev Cell Dev Biol23: 175-205, 2007.
7. Alvarez-GarciaI and MiskaEA: MicroRNA functions in animal development and human disease. Development132: 4653-4662, 2005.
8. LeungAK and SharpPA: MicroRNA functions in stress responses. Mol Cell40: 205-215, 2010.
9. YanB, ZhaoLH, GuoJT and ZhaoJL: miR-429 regulation of osmotic stress transcription factor 1 (OSTF1) in tilapia during osmotic stress. Biochem Biophys Res Commun426: 294-298, 2012.
10. DeSanoJT and XuL: MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J11: 682-692, 2009.
11. Esquela-KerscherA and SlackFJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer6: 259-269, 2006.
12. ZhuW, HeJ, ChenD, etal: Expression of miR-29c, miR-93 and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS One9: e87780, 2014.
13. SchultzNA, DehlendorffC, JensenBV, etal: MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA311: 392-404, 2014.
14. AhmedFE, AhmedNC, VosPW, etal: Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics10: 93-113, 2013.
15. LiJ, DuL, YangY, etal: MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett329: 84-90, 2013.
16. WangY, LiM, ZangW, etal: MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol (Dordr) 36: 385-394, 2013.
17. KrützfeldtJ, RajewskyN, BraichR, etal: Silencing of microRNAs invivo with 'antagomirs'. Nature438: 685-689, 2005.
18. YuanX, HeJ, SunF and GuJ: Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma. Int J Clin Exp Pathol6: 2651-2667, 2013.
19. KimCH, KimHK, RettigRL, etal: miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics4: 79, 2011.
20. WeiZ, JiangS, ZhangY, etal: The effect of microRNAs in the regulation of human CYP3A4: A systematic study using a mathematical model. Sci Rep4: 4283, 2014.
21. Suzuki T, Yasui W, Yokozaki H, Naka K, IshikawaT and TaharaE: Expression of the E2F family in human gastrointestinal carcinomas. Int JCancer81: 535-538, 1999.
22. Ciafre SA and GalardiS: microRNAs and RNA-binding proteins: A complex network of interactions and reciprocal regulations in cancer. RNA biol10: 935-942, 2013.
23. LaiJP, ChienJR, MoserDR, etal: hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growthfactor signaling. Gastroenterology126:231-248, 2004.
24. NojimaH: G1 and S-phase checkpoints, chromosome instability, and cancer. Methods Mol Biol280: 3-49, 2004.
25. HumbertPO, VeronaR, TrimarchiJM, RogersC, DandapaniS and LeesJA: E2f3 is critical for normal cellular proliferation. Genes Dev14: 690-703, 2000.
26. BartekJ and LukasJ: Mammalian G1-and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol13: 738-747, 2001.
27. LeeMY, MorenoCS and SaavedraHI: E2F activators signal and maintain centrosome amplification in breast cancer cells. Mol Cell Biol34: 2581-2599, 2014.
28. NevinsJR: The Rb/E2F pathway and cancer. Hum Mol Genet10: 699-703, 2001.
29. XiaoF, ZhangW, ChenL, etal: MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. J Transl Med11: 195, 2013.
30. LeoneG, DeGregoriJ, YanZ, etal: E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev12: 2120-2130, 1998.
31. OlssonAY, FeberA, EdwardsS, etal: Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene26: 1028-1037, 2007.
32. RenXS, YinMH, ZhangX, etal: Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett344: 195-203, 2014.
33. HollernDP, HoneysettJ, CardiffRD and AndrechekER: The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Mol Cell Biol 34: 3229-3243, 2014.